Fig. 2 | Scientific Reports

Fig. 2

From: Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation

Fig. 2

Partial response of the first case to NK cell therapy. (A, H) A decrease in the uptake of the right paravertebral lesion (at the level of T9–T10) is evident about four months after NK cell therapy (solid white arrows). (B, G) The diffuse uptake by bone is decreased four months after receiving NK cells (dotted white arrows). (B–D, G) MIBG uptake by a suspicious lymph node in the left paracaval region is dampened (red arrows). (E, F) A decrease in the general MIBG uptake within the torso can be seen.

Back to article page